CSL's blood payments in US come under the microscope
Australian Ethical is asking the biotech giant to clarify how it will manage the risks posed by people in the US making donations more frequently to supplement their income.
CSL's blood payments in US come under the microscope Advertisement CSL has been forced to defend the way it runs its blood plasma collection business in the US amid concerns the company will face increased scrutiny over how it handles the health and welfare of blood donors. Wealth manager Australian Ethical, which has $3.8 billion under management, is seeking clarity from the ASX- listed biotech giant on how it will manage the level and frequency of donation payments, at a time when unemployment is ramping up in the US. Plasma collection is a "moral maze" and the ethics are about to be front a
Explore this link on the map →related reading
- Will there be blood? Medical companies can't find it fast enoughsmh.com.au
- EU May Ban Payments for Milk, Sperm and Blood - Marginal REVOLUTIONmarginalrevolution.com
- The third wave of American philanthropy - by Nan Ransohoffnanransohoff.substack.com
- Compensating kidney donorsworksinprogress.co
- My Left Kidney - by Scott Alexander - Astral Codex Tenastralcodexten.com
- Le mirage des banques privées de cellules souches | Radio-Canadaici.radio-canada.ca
- Pharma donations to patient groups in Canada are shrouded in mysterystatnews.com
- Blood money: Bayer's inventory of HIV-contaminated blood products and third world hemophiliacs - PubMedpubmed.ncbi.nlm.nih.gov
- MacKenzie Scott's $26 Billion Sugar Pile | Garry's Listgarryslist.org
- We wish we’d written that: STAT staffers' favorite stories of 2022statnews.com
- What We Learned Doing Fast Grants | Futurefuture.a16z.com
- The Effective-Altruism Comebackweb.archive.org